Search Results - "Lebel, Francois"
-
1
Void content analysis and processing issues to minimize defects in liquid composite molding
Published in Polymer composites (01-01-2019)“…This investigation aims to study the impact of key process parameters dealing with the resin impregnation of fibrous reinforcements used in Liquid Composite…”
Get full text
Journal Article -
2
Influence of habitat features and hunter behavior on white-tailed deer harvest
Published in The Journal of wildlife management (01-09-2012)“…Sport hunting may help in controlling cervid populations over large areas. As with natural predators, several environmental factors can influence sport…”
Get full text
Journal Article -
3
Prediction of optimal flow front velocity to minimize void formation in dual scale fibrous reinforcements
Published in International journal of material forming (01-03-2014)“…Liquid Composite Molding (LCM) is an increasingly used class of processes to manufacture high performance composites. Engineering fabrics commonly used in LCM…”
Get full text
Journal Article -
4
Experimental characterization by fluorescence of capillary flows in dual-scale engineering fabrics
Published in Textile research journal (01-09-2013)“…Liquid composite molding (LCM) is an increasingly used family of processes to manufacture composite parts. In LCM, the fibrous reinforcement is first laid in a…”
Get full text
Journal Article -
5
Flow modeling of linear and nonlinear fluids in two and three scale fibrous fabrics
Published in International journal of material forming (01-04-2016)“…A crucial step in many composites manufacturing processes is the impregnation of fibrous medium with the resin. The fundamental property needed to quantify the…”
Get full text
Journal Article -
6
Prolonged Central Nervous System Response in a Patient With HER2 Mutant NSCLC Treated With First-Line Poziotinib
Published in JTO clinical and research reports (01-11-2020)Get full text
Journal Article -
7
Advanced thermal simulation of processes involving materials exhibiting fine-scale microstructures
Published in International journal of material forming (01-04-2016)“…Image-based simulation is being considered more and more in industrial applications, where more than simulate the expected reality it seems preferable to…”
Get full text
Journal Article -
8
A Randomized Clinical Trial of Recombinant Human Hyaluronidase-Facilitated Subcutaneous Versus Intravenous Rehydration in Mild to Moderately Dehydrated Children in the Emergency Department
Published in Clinical therapeutics (01-11-2012)“…Abstract Background Alternative treatment of dehydration is needed when intravenous (IV) or oral rehydration therapy fails. Subcutaneous (SC) hydration…”
Get full text
Journal Article -
9
Poziotinib shows activity and durability of responses in subgroups of previously treated EGFR exon 20 NSCLC patients
Published in Journal of clinical oncology (20-05-2020)“…Abstract only 9514 Background: Treatment of non-small cell lung cancer (NSCLC) with EGFR exon 20 mutations is an unmet medical need. Poziotinib is a potent…”
Get full text
Journal Article -
10
Cost-effectiveness of recombinant human hyaluronidase-facilitated subcutaneous versus intravenous rehydration in children with mild to moderate dehydration
Published in The American journal of emergency medicine (01-06-2013)“…Abstract Objective To evaluate the cost-effectiveness of recombinant human hyaluronidase–facilitated subcutaneous (rHFSC) fluid administration compared to…”
Get full text
Journal Article -
11
-
12
Poziotinib in Non-Small-Cell Lung Cancer Harboring HER2 Exon 20 Insertion Mutations After Prior Therapies: ZENITH20-2 Trial
Published in Journal of clinical oncology (01-03-2022)“…Insertion mutations in Erb-b2 receptor tyrosine kinase 2 gene ( or ) exon 20 occur in 2%-5% of non-small-cell lung cancers (NSCLCs) and function as an…”
Get full text
Journal Article -
13
MO29-5 Updated safety and efficacy of poziotinib in Japanese patients with non-small cell lung cancer: Phase 1 study
Published in Annals of oncology (01-07-2022)Get full text
Journal Article -
14
Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial
Published in Science translational medicine (14-08-2019)“…Human interleukin-12 (hIL-12) is a cytokine with anticancer activity, but its systemic application is limited by toxic inflammatory responses. We assessed the…”
Get more information
Journal Article -
15
Carboplatin and Etoposide With or Without Palifosfamide in Untreated Extensive-Stage Small-Cell Lung Cancer: A Multicenter, Adaptive, Randomized Phase III Study (MATISSE)
Published in Journal of clinical oncology (10-08-2017)“…Purpose To evaluate the efficacy of the addition of palifosfamide to carboplatin and etoposide in extensive stage (ES) small-cell lung cancer (SCLC). Patients…”
Get full text
Journal Article -
16
Abstract PD1-07: A Phase 2 study of poziotinib in patients with HER2-positive metastatic breast cancer heavily pre-treated with HER2-targeted therapy
Published in Cancer research (Chicago, Ill.) (15-02-2021)“…Abstract Background: Poziotinib is a novel pan-HER inhibitor that irreversibly blocks the EGFR family of tyrosine-kinase receptors and inhibits the…”
Get full text
Journal Article -
17
PICASSO III: A Phase III, Placebo-Controlled Study of Doxorubicin With or Without Palifosfamide in Patients With Metastatic Soft Tissue Sarcoma
Published in Journal of clinical oncology (10-11-2016)“…Purpose Palifosfamide is the active metabolite of ifosfamide and does not require prodrug activation, thereby avoiding the generation of toxic metabolites. The…”
Get full text
Journal Article -
18
Abstract CT116: Same-day administration of Eflapegrastim with chemotherapy enhances neutropenic recovery in neutropenic rats and in early-stage breast cancer patients
Published in Cancer research (Chicago, Ill.) (01-07-2021)“…Abstract Background: Chemotherapy-induced neutropenia increases the likelihood of life-threatening infections. Currently, long-acting G-CSF products are…”
Get full text
Journal Article -
19
Justification for a Fixed Dose of Eflapegrastim, a Long‐Acting G‐CSF, in Patients Receiving Docetaxel‐Cyclophosphamide Chemotherapy
Published in Journal of clinical pharmacology (01-02-2021)“…Eflapegrastim (Rolontis) is a long‐acting granulocyte colony‐stimulating factor (G‐CSF) produced by conjugating a human G‐CSF analogue and a human…”
Get full text
Journal Article -
20
Abstract OT-06-01: Open-label, phase 1 study to evaluate duration of severe neutropenia after same-day dosing of eflapegrastim in patients with breast cancer receiving docetaxel and cyclophosphamide (NCT04187898)
Published in Cancer research (Chicago, Ill.) (15-02-2021)“…Abstract Background: Eflapegrastim (Rolontis®, Efla) is a long-acting granulocyte-colony stimulating factor (G-CSF), consisting of a recombinant human G-CSF…”
Get full text
Journal Article